Cytokinetics Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Takes Center Stage ONC Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Slides 25 MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline KEX Q1 2026 Earnings EPS Beats Estimates by 66 Stock Edges Higher BLX Q1 2026 Earnings Earnings Per Share Reported at 131 Shares Dip 227 MLM Q1 2026 Earnings Slight EPS Miss Amid Solid Aggregate Demand